Kidney fibrosis is the hallmark of chronic kidney disease (CKD) and is characterized by an imbalanced extracellular matrix (ECM) remodeling. Collagen type III is one of the main ECM components of the interstitial matrix of the kidney. We hypothesized that measuring three biomarkers of collagen type III reflecting different aspects of this protein turnover (C3M, C3C, and PRO-C3) may provide different information about the fibrotic burden in patients with IgA nephropathy (IgAN). We examined a cohort of 134 patients with IgAN. The three collagen type III biomarkers were measured in serum (S) and in urine (U) samples taken on the same day before kidney biopsy was performed. Biopsies were evaluated for interstitial fibrosis and tubular atrophy, according to the Banff and MEST-C scores. S-PRO-C3 and S-C3C correlated with the degree of fibrosis in the biopsy, whereas U-C3M/Cr had an inverse correlation with fibrosis. U-C3M/Cr had the highest discrimination ability for advanced fibrosis, which was maintained after adjustment for the other collagen type III biomarkers, proteinuria, and serum creatinine. The data presented in this study indicate that measuring the different fragments of the same ECM protein and in different matrices provides a variety of information regarding pathological kidney tissue alterations in patients with IgAN.

Department of Clinical and Transplant Pathology Institute of Clinical and Experimental Medicine 140 21 Prague Czech Republic

Department of Nephrology 1st Faculty of Medicine and General University Hospital Charles University Prague 128 08 Prague Czech Republic

Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine and General University Hospital Charles University 128 08 Prague Czech Republic

Nordic Bioscience 2730 Herlev Denmark

Zobrazit více v PubMed

Penfold R.S., Prendecki M., McAdoo S., Tam F.W.K. Primary IgA Nephropathy: Current Challenges and Future Prospects. Int. J. Nephrol. Renovasc. Dis. 2018;11:137–148. PubMed PMC

Maixnerova D., Jancova E., Skibova J., Rysava R., Rychlik I., Viklicky O., Merta M., Kolsky A., Reiterova J., Neprasova M., et al. Nationwide Biopsy Survey of Renal Diseases in the Czech Republic during the Years 1994–2011. J. Nephrol. 2014;28:39–49. doi: 10.1007/s40620-014-0090-z. PubMed DOI

Suzuki H., Kiryluk K., Novak J., Moldoveanu Z., Herr A.B., Renfrow M.B., Wyatt R.J., Scolari F., Mestecky J., Gharavi A.G., et al. The Pathophysiology of IgA Nephropathy. J. Am. Soc. Nephrol. 2011;22:1795–1803. doi: 10.1681/ASN.2011050464. PubMed DOI PMC

Yeo S.C., Cheung C.K., Barratt J. New Insights into the Pathogenesis of IgA Nephropathy. Pediatr. Nephrol. 2018;33:763–777. doi: 10.1007/s00467-017-3699-z. PubMed DOI PMC

Kuivaniemi H., Tromp G. Type III Collagen (COL3A1): Gene and Protein Structure, Tissue Distribution, and Associated Diseases. Gene. 2019;707:151–171. doi: 10.1016/j.gene.2019.05.003. PubMed DOI PMC

Karsdal M.A., Genovese F., Rasmussen D.G.K., Bay-Jensen A.C., Mortensen J.H., Holm Nielsen S., Willumsen N., Jensen C., Manon-Jensen T., Jennings L., et al. Considerations for Understanding Protein Measurements: Identification of Formation, Degradation and More Pathological Relevant Epitopes. Clin. Biochem. 2021;97:11–24. doi: 10.1016/j.clinbiochem.2021.08.007. PubMed DOI

Genovese F., Manresa A.A., Leeming D.J., Karsdal M.A., Boor P. The Extracellular Matrix in the Kidney: A Source of Novel Non-Invasive Biomarkers of Kidney Fibrosis? Fibrogenes. Tissue Repair. 2014;7:4. doi: 10.1186/1755-1536-7-4. PubMed DOI PMC

Genovese F., Akhgar A., Lim S.S., Farris A.B., Sinibaldi D., Karsdal M.A., White W.I., Battle M., Cobb J. Collagen Type III and VI Remodeling Biomarkers Are Associated with Kidney Fibrosis in Lupus Nephritis. KIDNEY360. 2021;2:1473–1481. PubMed PMC

Genovese F., Rasmussen D.G.K., Karsdal M.A., Jesky M., Ferro C., Fenton A., Cockwell P. Imbalanced Turnover of Collagen Type III Is Associated with Disease Progression and Mortality in High-Risk Chronic Kidney Disease Patients. Clin. Kidney J. 2021;14:593–601. doi: 10.1093/ckj/sfz174. PubMed DOI PMC

Genovese F., Boor P., Papasotiriou M., Leeming D.J., Karsdal M.A., Floege J. Turnover of Type III Collagen Reflects Disease Severity and Is Associated with Progression and Microinflammation in Patients with IgA Nephropathy. Nephrol. Dial. Transplant. 2016;31:472–479. doi: 10.1093/ndt/gfv301. PubMed DOI

Rasmussen D.G.K., Sand J.M.B., Karsdal M.A., Genovese F. Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease. PLoS ONE. 2017;12:e0170023. doi: 10.1371/journal.pone.0170023. PubMed DOI PMC

Sparding N., Genovese F., Rasmussen D.G.K., Karsdal M.A., Neprasova M., Maixnerova D., Satrapova V., Frausova D., Hornum M., Bartonova L., et al. Endotrophin, a Collagen Type VI-Derived Matrikine, Reflects the Degree of Renal Fibrosis in Patients with IgA Nephropathy and in Patients with ANCA-Associated Vasculitis. Nephrol. Dial. Transplant. 2022;37:1099–1108. doi: 10.1093/ndt/gfab163. PubMed DOI PMC

Neprasova M., Maixnerova D., Sparding N., Genovese F., Karsdal M.A., Koprivova H., Kollar M., Suchanek M., Hruskova Z., Tesar V. Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy. Int. J. Mol. Sci. 2023;24:2064. doi: 10.3390/ijms24032064. PubMed DOI PMC

Levey A.S., Stevens L.A., Schmid C.H., Zhang Y., Castro III A.F., Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., et al. A New Equation to Estimate Glomerular Filtration Rate Disclosure of Conflicts of Interest: We Have Received Confirmation from Drs. Ann. Intern. Med. 2009;150:604–612. PubMed PMC

Loupy A., Haas M., Solez K., Racusen L., Glotz D., Seron D., Nankivell B.J., Colvin R.B., Afrouzian M., Akalin E., et al. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Am. J. Transplant. 2017;17:28–41. doi: 10.1111/ajt.14107. PubMed DOI PMC

Trimarchi H., Barratt J., Cattran D.C., Cook H.T., Coppo R., Haas M., Liu Z.-H., Roberts I.S.D., Yuzawa Y., Zhang H., et al. Oxford Classification of IgA Nephropathy 2016: An Update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91:1014–1021. doi: 10.1016/j.kint.2017.02.003. PubMed DOI

Nielsen M.J., Nedergaard A.F., Sun S., Veidal S.S., Larsen L., Zheng Q., Suetta C., Henriksen K., Christiansen C., Karsdal M.A., et al. The Neo-Epitope Specific PRO-C3 ELISA Measures True Formation of Type III Collagen Associated with Liver and Muscle Parameters. Am. J. Transl. Res. 2013;5:303–315. PubMed PMC

Barascuk N., Veidal S.S., Larsen L., Larsen D.V., Larsen M.R., Wang J., Zheng Q., Xing R., Cao Y., Rasmussen L.M., et al. A Novel Assay for Extracellular Matrix Remodeling Associated with Liver Fibrosis: An Enzyme-Linked Immunosorbent Assay (ELISA) for a MMP-9 Proteolytically Revealed Neo-Epitope of Type III Collagen. Clin. Biochem. 2010;43:899–904. doi: 10.1016/j.clinbiochem.2010.03.012. PubMed DOI

Papasotiriou M., Genovese F., Klinkhammer B.M., Kunter U., Nielsen S.H., Karsdal M.A., Floege J., Boor P. Serum and Urine Markers of Collagen Degradation Reflect Renal Fibrosis in Experimental Kidney Diseases. Nephrol. Dial. Transplant. 2015;30:1112–1121. doi: 10.1093/ndt/gfv063. PubMed DOI

Djudjaj S., Boor P. Cellular and Molecular Mechanisms of Kidney Fibrosis. Mol. Asp. Med. 2019;65:16–36. doi: 10.1016/j.mam.2018.06.002. PubMed DOI

Lennon R., Byron A., Humphries J.D., Randles M.J., Carisey A., Murphy S., Knight D., Brenchley P.E., Zent R., Humphries M.J. Global Analysis Reveals the Complexity of the Human Glomerular Extracellular Matrix. J. Am. Soc. Nephrol. 2014;25:939–951. doi: 10.1681/ASN.2013030233. PubMed DOI PMC

Du B., Yu M., Zheng J. Transport and Interactions of Nanoparticles in the Kidneys. Nat. Rev. Mater. 2018;3:358–374. doi: 10.1038/s41578-018-0038-3. DOI

Koide H., Nakamura T., Ebihara I., Tomino Y. Increased MRNA Expression of Metalloproteinase-9 in Peripheral Blood Monocytes from Patients with Immunoglobulin A Nephropathy. Am. J. Kidney Dis. 1996;28:32–39. doi: 10.1016/S0272-6386(96)90127-4. PubMed DOI

Paunas F.T.I., Finne K., Leh S., Osman T.A.-H., Marti H.-P., Berven F., Vikse B.E. Characterization of Glomerular Extracellular Matrix in IgA Nephropathy by Proteomic Analysis of Laser-Captured Microdissected Glomeruli. BMC Nephrol. 2019;20:410. doi: 10.1186/s12882-019-1598-1. PubMed DOI PMC

Cocchiaro P., De Pasquale V., Morte R.D., Tafuri S., Avallone L., Pizard A., Moles A., Pavone L.M. The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease. Front. Cell Dev. Biol. 2017;5:114. doi: 10.3389/fcell.2017.00114. PubMed DOI PMC

Zhao J., Yang Y., Wu Y. The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy. Front. Pediatr. 2021;9:631473. doi: 10.3389/fped.2021.631473. PubMed DOI PMC

Cao Y., Liu X., Li Y., Lu Y., Zhong H., Jiang W., Chen A.F., Billiar T.R., Yuan H., Cai J. Cathepsin L Activity Correlates with Proteinuria in Chronic Kidney Disease in Humans. Int. Urol. Nephrol. 2017;49:1409–1417. doi: 10.1007/s11255-017-1626-7. PubMed DOI